↓ Skip to main content

Carbamazepine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
15 tweeters

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Carbamazepine for schizophrenia
Published in
Cochrane database of systematic reviews, May 2014
DOI 10.1002/14651858.cd001258.pub3
Pubmed ID
Authors

Stefan Leucht, Bartosz Helfer, Markus Dold, Werner Kissling, John McGrath

Abstract

Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 <1%
Unknown 109 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 25%
Student > Bachelor 14 13%
Researcher 14 13%
Student > Ph. D. Student 12 11%
Student > Doctoral Student 9 8%
Other 33 30%
Readers by discipline Count As %
Medicine and Dentistry 50 45%
Psychology 15 14%
Unspecified 15 14%
Nursing and Health Professions 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Other 14 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2016.
All research outputs
#2,335,590
of 13,484,970 outputs
Outputs from Cochrane database of systematic reviews
#5,095
of 10,619 outputs
Outputs of similar age
#33,763
of 188,910 outputs
Outputs of similar age from Cochrane database of systematic reviews
#102
of 200 outputs
Altmetric has tracked 13,484,970 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,619 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,910 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 200 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.